Ketoconazole: assessing its risks.
作者信息
Stern R S
出版信息
J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):544. doi: 10.1016/s0190-9622(82)80370-8.
PMID:6281317
Abstract
摘要
相似文献
1
Ketoconazole: assessing its risks.
J Am Acad Dermatol. 1982 Apr;6(4 Pt 1):544. doi: 10.1016/s0190-9622(82)80370-8.
2
Toxic hepatis during ketoconazole treatment.
Br Med J (Clin Res Ed). 1981 Sep 26;283(6295):825-6. doi: 10.1136/bmj.283.6295.825.
3
Hepatitis and ketoconazole therapy.
Br Med J (Clin Res Ed). 1981 Oct 17;283(6298):1058-9.
4
Hepatic dysfunction and ketoconazole therapy.
Ann Intern Med. 1982 Jun;96(6 Pt 1):788-9. doi: 10.7326/0003-4819-96-6-788_2.
5
[Toxic hepatitis caused by ketoconazole].
Ned Tijdschr Geneeskd. 1983 Jun 18;127(25):1114-5.
6
[Toxic hepatitis during the administration of ketoconazole (Nizoral)].
Ned Tijdschr Geneeskd. 1983 Feb 19;127(8):343-4.
7
[Toxic hepatitis caused by ketoconazole (Nizoral)].
Ned Tijdschr Geneeskd. 1983 Feb 19;127(8):341-3.
8
[Hepatitis during the administration of ketoconazole (Nizoral)].
Ned Tijdschr Geneeskd. 1983 Feb 19;127(8):339-41.
9
Severe hepatitis associated with ketoconazole therapy for chronic mucocutaneous candidiasis.
Cutis. 1982 May;29(5):482-4.
10
Severe hepatitis during ketoconazole therapy.
Gastroenterol Jpn. 1983 Apr;18(2):142-7. doi: 10.1007/BF02774689.
Zotero 插件